European Healthtech startup funding raised during May 2025.
In May 2025, 47 European Healthtech companies raised a combined €739M across 47 funding rounds, down 14.3% versus May 2024. Switzerland led by capital raised, and Sofinnova Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Azafaros | Series B | May 2025 | €132M |
| GlycoEra | Series B | May 2025 | €114M |
| Juvenescence | Series B | May 2025 | €67M |
| haya therapeutics | Series A |
4 exits.
| May 2025 |
| €58M |
| ReproNovo | Series A | May 2025 | €57M |
| Salvia BioElectronics | Series B | May 2025 | €53M |
| Hilo (Aktiia) | Series B | May 2025 | €37M |
| SafeHeal | Series C | May 2025 | €35M |
| Tilt Biotherapeutics | Series B | May 2025 | €22M |
| SeqOne | Other | May 2025 | €20M |
| Optics11 | Other | May 2025 | €17M |
| Hedera Dx | Series A | May 2025 | €15M |
| Dawn Health | Other | May 2025 | €12M |
| Ethris | Grant | May 2025 | €10M |
| Surgify Medical | Series A | May 2025 | €7.0M |
